Parathyroid carcinoma

Last updated
Parathyroid carcinoma
Parathyroid es.svg
Parathyroid gland anatomy(green marks)
Specialty Oncology, ENT surgery

Parathyroid carcinoma is a rare cancer resulting in parathyroid adenoma to carcinoma progression. [1] It forms in tissues of one or more of the parathyroid glands (four pea-sized glands in the neck that make parathyroid hormone (PTH). PTH helps the body maintain normal levels of serum calcium by promoting calcium reabsorption from bone. It is antagonized by the hormone calcitonin, which prompts calcium storage.).

Contents

It is rare—with documented cases of less than one thousand since its first discovery in 1904 [2] [3] [4] [5] [6] [7] —and much less common than parathyroid adenoma. It can be difficult to excise. [8] The rate of occurrence of parathyroid carcinoma is between 0.5% to 5%. [9] [10] [6] [11]

Signs and symptoms

Most patients experience moderate to severe hypercalcemia and high parathyroid hormone levels. A large mass in the neck is often seen, and kidney and bone abnormalities are common. [1]

Risk factors

Parathyroid cancer occurs in midlife at the same rate in men and women. [12]

Conditions that appear to result in an increased risk of parathyroid cancer include multiple endocrine neoplasia type 1, [13] autosomal dominant familial isolated hyperparathyroidism [13] and hyperparathyroidism-jaw tumor syndrome [1] (which also is hereditary). [1] Parathyroid cancer has also been associated with external radiation exposure, but most reports describe an association between radiation and the more common parathyroid adenoma. [13]

Diagnosis

On Sestamibi parathyroid scan, intense radioactivity greater than submandibular gland on delayed image, no washout between early and delayed images, and high concentration of parathyroid hormone concentration in blood in those who age more than 40 years is suggestive of parathyroid carcinoma. [14] Some authors suggest high levels of HCG as a marker for parathyroid carcinoma in the right context. [15] However, other thyroid diseases such as multinodular goitre, Hashimoto thyroiditis, thyroid adenoma, and thyroid carcinoma also retains the radiotracer because of high metabolic nature of these diseases. [16] Thus, the final diagnosis always requires pathological examination of the tissue in question.

Treatment

Parathyroid carcinoma is sometimes diagnosed during surgery for primary hyperparathyroidism. If the surgeon suspects carcinoma based on severity or invasion of surrounding tissues by a firm parathyroid tumor, aggressive excision is performed, including the thyroid and surrounding tissues as necessary. [1]

Agents such as calcimimetics (for example, cinacalcet) are used to mimic calcium and are able to activate the parathyroid calcium-sensing receptor (making the parathyroid gland "think" we have more calcium than we actually do), therefore lowering the calcium level, in an attempt to decrease the hypercalcemia. [17]

References

  1. 1 2 3 4 5 Hu MI, Vassilopoulou-Sellin R, Lustig R, Lamont JP. "Thyroid and Parathyroid Cancers" Archived 2010-02-28 at the Wayback Machine in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach Archived 2013-10-04 at the Wayback Machine . 11 ed. 2008.
  2. ↑ Givi B, Shah JP (August 2010). "Parathyroid carcinoma". Clinical Oncology. 22 (6): 498–507. doi:10.1016/j.clon.2010.04.007. PMC   3781923 . PMID   20510594.
  3. ↑ Wei CH, Harari A (March 2012). "Parathyroid carcinoma: update and guidelines for management". Current Treatment Options in Oncology. 13 (1): 11–23. doi:10.1007/s11864-011-0171-3. PMID   22327883. S2CID   39872789.
  4. ↑ Dudney WC, Bodenner D, Stack BC (April 2010). "Parathyroid carcinoma". Otolaryngologic Clinics of North America. Thyroid and Parathyroid Surgery. 43 (2): 441–53, xi. doi:10.1016/j.otc.2010.01.011. PMID   20510726.
  5. ↑ Beus KS, Stack BC (August 2004). "Parathyroid carcinoma". Otolaryngologic Clinics of North America. Parathyroids. 37 (4): 845–54, x. doi:10.1016/j.otc.2004.02.014. PMID   15262520.
  6. 1 2 Healy SJ, Soe KK (2016-06-01). "Parathyroid Cancer Cases: A Single Center's Experience". AACE Clinical Case Reports. 2 (3): e221 –e227. doi: 10.4158/EP15857.CR . ISSN   2376-0605.
  7. ↑ Lee JE (July 2005). "Predicting the presence of parathyroid carcinoma". Annals of Surgical Oncology. 12 (7): 513–514. doi:10.1245/ASO.2005.03.904. PMID   15952075. S2CID   195245925.
  8. ↑ "Endocrine Pathology" . Retrieved 2009-05-08.
  9. ↑ Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA (July 1992). "Parathyroid carcinoma: clinical and pathologic features in 43 patients". Medicine. 71 (4): 197–205. doi: 10.1097/00005792-199207000-00002 . PMID   1518393. S2CID   25457018.
  10. ↑ Mohebati A, Shaha A, Shah J (December 2012). "Parathyroid carcinoma: challenges in diagnosis and treatment". Hematology/Oncology Clinics of North America. Rare Cancers. 26 (6): 1221–1238. doi:10.1016/j.hoc.2012.08.009. PMID   23116578.
  11. ↑ Givi B, Shah JP (August 2010). "Parathyroid carcinoma". Clinical Oncology. 22 (6): 498–507. doi:10.1016/j.clon.2010.04.007. PMC   3781923 . PMID   20510594.
  12. ↑ Givi B, Shah JP (August 2010). "Parathyroid carcinoma". Clinical Oncology. 22 (6): 498–507. doi:10.1016/j.clon.2010.04.007. PMC   3781923 . PMID   20510594.
  13. 1 2 3 "Parathyroid Cancer Treatment". National Cancer Institute. 11 March 2009.
  14. ↑ Cheon M, Choi JY, Chung JH, Lee JY, Cho SK, Yoo J, et al. (December 2011). "Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism". Nuclear Medicine and Molecular Imaging. 45 (4): 276–284. doi:10.1007/s13139-011-0103-y. PMC   4043053 . PMID   24900018.
  15. ↑ Valdes-Socin H, Betea D, Daly A, Delanaye P, Souberbielle JC, Beckers A, Cavalier E (2018-05-08). "Human Chorionic Gonadotrophin (hCG) as a diagnostic test to differentiate between Parathyroid Carcinoma, Primary Benign Hyperparathyroidism and Secondary Hyperparathyroidism" . Endocrine Abstracts. 56. Bioscientifica. doi:10.1530/endoabs.56.P214.
  16. ↑ Nguyen BD (May 1999). "Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy". Radiographics. 19 (3): 601–614. doi:10.1148/radiographics.19.3.g99ma10601. PMID   10336191.
  17. ↑ Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF (9 December 2014). "Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients". The Cochrane Database of Systematic Reviews. 2014 (12). John Wiley & Sons, Ltd: CD006254. doi:10.1002/14651858.CD006254.pub2. PMC   10614033 . PMID   25490118. p. 2: Cinacalcet decreased serum PTH […] and calcium […] levels[…].

PD-icon.svg This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.